-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, H54agw203buaDb4YfJo0YqEFI69ZAOsKsDtzJ5x5bv1HU/IMPddtvY5lTBnaTEzp 3zkpVDsLZUVOqt/E1zpIvA== 0000914121-99-000947.txt : 19991018 0000914121-99-000947.hdr.sgml : 19991018 ACCESSION NUMBER: 0000914121-99-000947 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19990930 FILED AS OF DATE: 19991012 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: OXIGENE INC CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: SEC FILE NUMBER: 000-21990 FILM NUMBER: 99727084 BUSINESS ADDRESS: STREET 1: ONE COPLEY PLACE STREET 2: SUITE 602 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 2124310001 MAIL ADDRESS: STREET 1: ONE COPLEY PLACE, SUITE 602 CITY: BOSTON STATE: MA ZIP: 02116 COMPANY DATA: COMPANY CONFORMED NAME: NORDENVALL BJORN CENTRAL INDEX KEY: 0001071675 STANDARD INDUSTRIAL CLASSIFICATION: [] OFFICER FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: C/O OXIGENE INC STREET 2: ONE COPELY PLACE, SUITE 602 CITY: BOSTON STATE: MA ZIP: 02116 MAIL ADDRESS: STREET 1: C/O OXIGENE INC STREET 2: ONE COPLEY PLACE, SUITE 602 CITY: BOSTON STATE: MA ZIP: 02116 4 1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP - ------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION ------------------------------ FORM 4 Washington, D.C. 20549 OMB Approval - ------------------------- STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP ------------------------------ [ ] Check this box if no OMB Number: 3235-0287 longer subject to Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Expires: September 30, 1998 Section 16. Form 4 Section 17(a) of the Public Utility Holding Company Act of 1935 or Estimated average burden or Form 5 obligations Section 30(f) of the Investment Company Act of 1940 hours per response.......0.5 may continue. See ------------------------------ Instruction 1(b).
(Print or Type Responses) - ------------------------------------------------------------------------------------------------------------------------------------ 1. Name and Address of Reporting Person* 2. Issuer Name and Ticker 4. Statement for 6. Relationship of Reporting Person(s) or Trading Symbol Month/Year to Issuer (Check all applicable) NORDENVALL, BJORN OXiGENE Inc. (OXGN) 9/1999 [X] Director [ ] 10% Owner ------------------------------------ [X] Officer (give [ ] Other (Last) (First) (Middle) title below) (specify below) c/o OXiGENE, Inc. Chief Executive Officer One Copley Place, Suite 602 --------------------------------------- ------------------------------------ ----------------------------------------------------------------------------------------- (Street) 3. I.R.S. Identification 5. If Amendment, 7. Individual or Joint/Group Filing Number of Reporting Date of (Check Applicable Line) Person, if an entity Original [X] Form Filed by One Reporting Person Boston, MA 02116 (Voluntary) (Month/Year) [ ] Form Filed by More than One ------------------------------------ Reporting Person (City) (State) (Zip) - ------------------------------------------------------------------------------------------------------------------------------------ TABLE I -- NON-DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED - ------------------------------------------------------------------------------------------------------------------------------------ 1. Title of Security 2. Trans- 3. Transaction 4. Securities Acquired (A) 5. Amount of 6. Ownership 7. Nature of (Instr. 3) action Code (Instr. or Disposed of (D) Securities Form: Indirect Date 8) (Instr. 3, 4 and 5) Beneficially Direct (D) Beneficial (Month/ Owned at End or Indirect Ownership Day/ of Month (I) (Instr. 4) Year) (Instr. 3 (Instr. 4) and 4) - ------------------------------------------------------------------------------------------------------------------------------------ Code V Amount (A) or (D) Price - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 09/01/99 A 40,000 A $9.6880 255,500 I (1) - ------------------------------------------------------------------------------------------------------------------------------------ 70 I (2) - ------------------------------------------------------------------------------------------------------------------------------------ 22,000 (3) - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4(b)(v). Page 1 of 2
FORM 4 (continued)
TABLE II -- DERIVATIVE SECURITIES BENEFICIALLY OWNED (E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES) - ------------------------------------------------------------------------------------------------------------------------------------ 1. Title 2. Conver- 3. Trans- 4. Trans- 5. Number of 6. Date 7. Title 8. Price 9. Number 10. Owner- 11. Nature of of sion or action action Derivative Exer- and of of ship Indirect Deri- Exercise Date Code Securities cisable Amount Deri- Deri- Form Beneficial vative Price of (Instr. Acquired (A) and Expi- of vative vative of Deri- Ownership Secu- Deri- (Month/ 8) or Disposed ration Under- Secu- Secu- vative (Instr. 4) rity vative Day/ of (D) Date lying rity rities Security: (Instr. Security Year) (Instr. 3, (Month/ Securi- (Instr. Benefi- Direct 3) 4, and 5) Day/ ties 5) cially (D) or Year) (Instr. Owned Indirect 3 and 4) at End (I) of (Instr. Month 4) (Instr. 4) - ------------------------------------------------------------------------------------------------------------------------------------ Code V (A) (D) Date Expir- Title Amount Exerci- ation or sable Date Number of Shares - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock $9.6880 9/1/99 A 40,000 Immed. 9/1/09 Common 40,000 40,000 I (1) Option Stock (right to purchase)(4) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock $9.6880 9/1/99 D 40,000 Immed. 9/1/09 Common 40,000 0 Option Stock (right to purchase)(4) - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ Explanation of Responses: (1) Shares are held by a corporation organized under the laws of Sweden of which the reporting person is the sole stockholder. (2) Shares are held by daughter. (3) Shares are held through capital insurance placed by the reporting person. (4) The Common Stock Options were issued pursuant to the OXiGENE 1996 Stock Incentive Plan, as amended and, in accordance with the laws of Sweden, were immediately exercisable upon the date of grant, subject to a right of repurchase by OXiGENE. The reporting person exercised the Common Stock Options on 9/1/99 by executing a promissory note in the amount of the aggregate exercise price, payable to OXiGENE and secured by the shares of Common Stock purchased by the reporting person. ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. and 15 U.S.C. 78ff(a). By: /S/ BJORN NORDENVALL October 12, 1999 ------------------------------------- ------------------------- Bjorn Nordenvall Date Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless form displays a currently valid OMB number. Page 2 of 2
-----END PRIVACY-ENHANCED MESSAGE-----